These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 19654237

  • 1. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC, Enea D, Ferketich AK, Lu B, Nencini P.
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB.
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N, Nikoloutsou I, Katsani G, Dima E, Fransis K, Roussos C, Gratziou C.
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [Abstract] [Full Text] [Related]

  • 6. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM, Mariante de Abreu C, Haggsträm FM, Wagner MB, Fritscher CC.
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
    Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC.
    Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [Abstract] [Full Text] [Related]

  • 14. Bupropion for smoking cessation: a randomized trial.
    Simon JA, Duncan C, Carmody TP, Hudes ES.
    Arch Intern Med; 2004 Sep 13; 164(16):1797-803. PubMed ID: 15364675
    [Abstract] [Full Text] [Related]

  • 15. Acceptance of nicotine dependence treatment among currently depressed smokers.
    Haug NA, Hall SM, Prochaska JJ, Rosen AB, Tsoh JY, Humfleet G, Delucchi K, Rossi JS, Redding CA, Eisendrath S.
    Nicotine Tob Res; 2005 Apr 13; 7(2):217-24. PubMed ID: 16036278
    [Abstract] [Full Text] [Related]

  • 16. High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
    Sundblad BM, Larsson K, Nathell L.
    Nicotine Tob Res; 2008 May 13; 10(5):883-90. PubMed ID: 18569763
    [Abstract] [Full Text] [Related]

  • 17. [Effect of treatment for nicotine dependence in patients with COPD].
    Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J.
    Pneumonol Alergol Pol; 2003 May 13; 71(9-10):411-7. PubMed ID: 15052977
    [Abstract] [Full Text] [Related]

  • 18. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD.
    Nicotine Tob Res; 2009 Mar 13; 11(3):234-9. PubMed ID: 19246427
    [Abstract] [Full Text] [Related]

  • 19. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C.
    Biol Psychiatry; 2007 Jan 01; 61(1):111-8. PubMed ID: 16876132
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of bupropion therapy for smoking cessation during routine clinical use.
    Paluck EC, McCormack JP, Ensom MH, Levine M, Soon JA, Fielding DW.
    Ann Pharmacother; 2006 Feb 01; 40(2):185-90. PubMed ID: 16434561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.